Charles Garner - Aileron Therapeutics Principal Officer
| ALRNDelisted Stock | USD 2.11 0.15 7.65% |
Executive
Charles Garner is Principal Officer of Aileron Therapeutics
| Age | 48 |
| Phone | 737 802 1989 |
| Web | https://www.aileronrx.com |
Aileron Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.2586) % which means that it has lost $0.2586 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4432) %, meaning that it created substantial loss on money invested by shareholders. Aileron Therapeutics' management efficiency ratios could be used to measure how well Aileron Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Amy CFA | Assembly Biosciences | N/A | |
| YuWaye MD | CytomX Therapeutics | 57 | |
| Moses Makunje | Nuvation Bio | 45 | |
| MBA MBA | Bio Path Holdings | N/A | |
| Anthony Price | Bio Path Holdings | N/A | |
| Danielle OlanderMoghadassian | CytomX Therapeutics | N/A | |
| Jeanette Bjorkquist | Assembly Biosciences | N/A | |
| MPH MD | Salarius Pharmaceuticals | N/A | |
| Bryan Dulhunty | Benitec Biopharma Ltd | N/A | |
| Chau MBA | CytomX Therapeutics | N/A | |
| Jonathan Zung | Curis Inc | 60 | |
| Mark Noel | Curis Inc | 66 | |
| John Sharkey | GeoVax Labs | 69 | |
| Philippe Sauvage | Nuvation Bio | 48 | |
| Andrew Yates | Artelo Biosciences | N/A | |
| John Niles | GeoVax Labs | N/A | |
| Colleen Sjogren | Nuvation Bio | 55 | |
| Robert MBBS | Instil Bio | N/A | |
| Claudia Kloth | Benitec Biopharma Ltd | N/A | |
| Dawn Benson | CytomX Therapeutics | N/A | |
| Richard Colonno | Assembly Biosciences | 74 | |
Management Performance
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.26 |
Aileron Therapeutics Leadership Team
Elected by the shareholders, the Aileron Therapeutics' board of directors comprises two types of representatives: Aileron Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aileron. The board's role is to monitor Aileron Therapeutics' management team and ensure that shareholders' interests are well served. Aileron Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aileron Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charles Garner, Principal Officer | ||
| Allen Annis, Vice President - Biophysical and Analytical Technologies | ||
| James Windsor, COO President | ||
| Brian Windsor, COO President |
Aileron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aileron Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 28.45 M | ||||
| Shares Outstanding | 21.67 M | ||||
| Shares Owned By Insiders | 0.60 % | ||||
| Shares Owned By Institutions | 28.47 % | ||||
| Number Of Shares Shorted | 141.21 K | ||||
| Price To Earning | (0.31) X | ||||
| Price To Book | 0.91 X | ||||
| Gross Profit | (17.01 M) |
Pair Trading with Aileron Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aileron Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Aileron Stock
Moving against Aileron Stock
| 0.88 | DRTS | Alpha Tau Medical | PairCorr |
| 0.87 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.79 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.73 | VCYT | Veracyte Potential Growth | PairCorr |
| 0.66 | VCEL | Vericel Corp Ord | PairCorr |
The ability to find closely correlated positions to Aileron Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aileron Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aileron Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aileron Therapeutics to buy it.
The correlation of Aileron Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aileron Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aileron Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aileron Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aileron Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Aileron Stock
If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |